Market Overview:
The global cell viability assay market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for cell-based assays for drug discovery and development, rising prevalence of chronic diseases, and growing investments in life sciences research. The human cells segment is expected to account for the largest share of the global cell viability assay market in 2018. This segment is driven by the increasing demand for human cells from pharmaceutical and biotechnology companies, academic and research institutes, hospital and diagnostic laboratories, and others for drug discovery and development purposes. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period owing to factors such as rising awareness about advanced technologies used in cell-based assays, growing investments by leading players in this region, expanding healthcare infrastructure, and rising prevalence of chronic diseases.
Product Definition:
Cell viability assays are used to determine the number of viable cells in a sample. This information can be used to monitor the health of a cell population or to assess the toxicity of a compound.
Human Cells:
Human cells are used in research and development activities for the study of human diseases. They are also employed as a source of renewable material for the production of drugs and other therapeutic products. The factors that propel their demand include increasing incidences of chronic diseases, such as cancer, diabetes, cardiovascular disorders; rising expenditure on R&D by biotechnology companies; growing awareness about stem cell therapy among healthcare professionals & patients; and favorable government initiatives pertaining to human cell culture & research.
Microbial Cells:
Microbial cells are used for the detection of cell viability by measuring their ability to divide in a given environment. These cells can be derived from microbes such as yeast, bacteria and fungi. The most commonly used microbial cell line is HeLa which is a human cancer cell line that has been widely adopted owing to its ease of availability and high proliferative ability. Other types of microbial cells include MRC-5, HEY & 3T3 etc.
Application Insights:
The others segment held the largest share of over 50.0% in 2017 and is expected to witness significant growth during the forecast period owing to increasing demand for vaccines from developing countries. The pharmaceutical and biotechnology companies are also anticipated to hold lucrative market share during the forecast period owing to extensive usage of mammalian cell cultivation techniques for producing therapeutic proteins.
Cell-based research has revolutionized modern medicine by providing a reliable method for studying human diseases at their initial stages, before they develop into full blown symptoms or complications. This approach is known as preclinical cell research, which involves testing new drugs on cells that are derived from patients with similar characteristics as those found in humans (i.e., genetic makeup). Thus, growing demand for such therapies is expected drive this application segment over the projected period due to rising R&D activities undertaken by various companies across the globe including Merck KGaA, Inc., Pfizer Canada Ltd., sanofi pasteur ltd.
Regional Analysis:
North America held the largest revenue share in 2017. The presence of major players, advanced healthcare infrastructure and high adoption rate for advanced therapies are some of the factors responsible for its large share. Moreover, increasing R&D activities to develop novel therapeutics is also expected to drive this market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising investments by various governments in developing cell and gene therapy research infrastructure as well as academic & research institutes. In addition, growing awareness regarding clinical trials among patients coupled with a large patient pool present throughout this region will support regional market growth during the same period.
Growth Factors:
- Increasing demand for cell-based assays in drug discovery and development processes
- Rising prevalence of chronic diseases, which is expected to increase the demand for cell-based therapies
- Technological advancements in cell viability assay platforms
- Growing number of biotechnology and pharmaceutical companies investing in R&D activities
- Increasing awareness about the benefits of using cell viability assays
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell Viability Assays Market Research Report
By Type
Human Cells, Microbial Cells, Animal Cells
By Application
Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospital and Diagnostic Laboratories, Others
By Companies
Thermo Fisher Scientific, Merck, Bio-Rad, GE, Danaher, BD, PerkinElmer, Promega, Biotium, Abcam, Creative Bioarray, Biotek Instruments
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Cell Viability Assays Market Report Segments:
The global Cell Viability Assays market is segmented on the basis of:
Types
Human Cells, Microbial Cells, Animal Cells
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospital and Diagnostic Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Merck
- Bio-Rad
- GE
- Danaher
- BD
- PerkinElmer
- Promega
- Biotium
- Abcam
- Creative Bioarray
- Biotek Instruments
Highlights of The Cell Viability Assays Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Human Cells
- Microbial Cells
- Animal Cells
- By Application:
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Hospital and Diagnostic Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell Viability Assays Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell viability assays are a type of scientific assay that can be used to measure the ability of cells to survive in vitro. Cell viability assays typically involve the use of a cell culture medium or other treatment that causes cells to die, and then measuring the amount of surviving cells.
Some of the major companies in the cell viability assays market are Thermo Fisher Scientific, Merck, Bio-Rad, GE, Danaher, BD, PerkinElmer, Promega, Biotium, Abcam, Creative Bioarray, Biotek Instruments.
The cell viability assays market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell Viability Assays Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cell Viability Assays Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cell Viability Assays Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cell Viability Assays Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cell Viability Assays Market Size & Forecast, 2020-2028
4.5.1 Cell Viability Assays Market Size and Y-o-Y Growth
4.5.2 Cell Viability Assays Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Human Cells
5.2.2 Microbial Cells
5.2.3 Animal Cells
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Pharmaceutical and Biotechnology Companies
6.2.2 Academic and Research Institutes
6.2.3 Hospital and Diagnostic Laboratories
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell Viability Assays Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell Viability Assays Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Human Cells
9.6.2 Microbial Cells
9.6.3 Animal Cells
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Pharmaceutical and Biotechnology Companies
9.10.2 Academic and Research Institutes
9.10.3 Hospital and Diagnostic Laboratories
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Human Cells
10.6.2 Microbial Cells
10.6.3 Animal Cells
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Pharmaceutical and Biotechnology Companies
10.10.2 Academic and Research Institutes
10.10.3 Hospital and Diagnostic Laboratories
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Human Cells
11.6.2 Microbial Cells
11.6.3 Animal Cells
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Pharmaceutical and Biotechnology Companies
11.10.2 Academic and Research Institutes
11.10.3 Hospital and Diagnostic Laboratories
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Human Cells
12.6.2 Microbial Cells
12.6.3 Animal Cells
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Pharmaceutical and Biotechnology Companies
12.10.2 Academic and Research Institutes
12.10.3 Hospital and Diagnostic Laboratories
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Human Cells
13.6.2 Microbial Cells
13.6.3 Animal Cells
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Pharmaceutical and Biotechnology Companies
13.10.2 Academic and Research Institutes
13.10.3 Hospital and Diagnostic Laboratories
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell Viability Assays Market: Competitive Dashboard
14.2 Global Cell Viability Assays Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Merck
14.3.3 Bio-Rad
14.3.4 GE
14.3.5 Danaher
14.3.6 BD
14.3.7 PerkinElmer
14.3.8 Promega
14.3.9 Biotium
14.3.10 Abcam
14.3.11 Creative Bioarray
14.3.12 Biotek Instruments
